Skip to content
Search

Latest Stories

High salt intake causes cognitive impairment linked to hypertension, study finds

The hormone Angiotensin II (Ang II) and its receptor “AT1” are recognized for their crucial role in regulating blood pressure and fluid balance

High salt intake causes cognitive impairment linked to hypertension, study finds

Researchers have discovered a correlation between hypertension, resulting from high salt intake, and emotional and cognitive dysfunction according to a recent study conducted by Fujita Health University in Japan.

The study reveals that excessive consumption of table salt, a commonly used food seasoning, has been associated with cognitive impairment.


Additionally, it is well-established that high salt intake is a contributing factor to the development of hypertension.

The study further explains that the mechanism behind this link involves disrupted signalling between the blood pressure regulation system and specific lipid molecules in the brain, ultimately leading to dysfunction.

The hormone Angiotensin II (Ang II) and its receptor "AT1" are recognized for their crucial role in regulating blood pressure and fluid balance.

Previous research has established the connection between Ang II-AT1 and the physiologically significant lipid molecule prostaglandin E2 (PGE2) and its receptor "EP1" in relation to hypertension and neurotoxicity.

However, the precise involvement of these systems in hypertension caused by high salt intake (HS) and its impact on emotional and cognitive functioning has remained unclear.

The recent study, published in the British Journal of Pharmacology, sheds light on this matter by demonstrating how the crosstalk between Ang II-AT1 and PGE2-EP1 contributes to HS-mediated hypertension and subsequent emotional and cognitive dysfunction.

"Excessive salt intake is considered a risk factor for hypertension, cognitive dysfunction, and dementia. However, studies focusing on the interaction between the peripheral and central nervous system have not sufficiently investigated this association," said author Hisayoshi Kubota from the university's Graduate School of Health Science.

The study observed that in mice, the emotional and cognitive effects were mainly attributed to tau phosphorylation, which refers to the excessive addition of phosphates to the protein called "tau."

Tau is a crucial protein associated with Alzheimer's disease.

During the study, the researchers administered a high-salt (HS) solution (consisting of 2% sodium chloride in drinking water) to laboratory mice for a duration of 12 weeks while closely monitoring their blood pressure.

"The effects of HS intake on emotional/cognitive function and tau phosphorylation were also examined in two key areas of the mouse brain - the prefrontal cortex and the hippocampus," explained Akihiro Mouri, professor at the university's School of Health Sciences.

Additionally, the researchers investigated the role of the Ang II-AT1 and PGE2-EP1 systems in high-salt (HS) induced hypertension and neuronal/behavioural impairment. The study revealed several biochemical changes in the brains of the mice.

Apart from tau phosphorylation, the researchers observed a reduction in the phosphate groups associated with a crucial enzyme called "CaMKII" at the molecular level. CaMKII is a protein involved in signalling processes in the brain.

Moreover, they detected alterations in the levels of "PSD95," a critical protein responsible for organizing and facilitating the connections between brain cells, known as synapses.

Interestingly, all these biochemical changes were observed to be reversed when the mice were administered the antihypertensive drug "losartan."

Similarly, the researchers noted a comparable reversal when the EP1 gene was knocked out.

The findings of the study indicate that the angiotensin II-AT1 and prostaglandin E2-EP1 systems could serve as promising targets for therapeutic interventions against dementia induced by hypertension.

In order to mitigate potential health risks, the World Health Organization advises restricting daily salt intake to less than 5 grams.

(PTI)

More For You

Robbie Williams

he 51-year-old, who has been using Mounjaro, believes the jab may be behind the sudden decline

Getty Images

Robbie Williams says weight-loss jabs are harming his eyesight as vision worsens

Highlights

  • Singer links rapidly deteriorating eyesight to Mounjaro injections
  • Says he struggles to see faces while performing live
  • Urges fans to research side effects before using weight-loss drugs
  • Notes the injections have eased long-standing mental health pressures

Robbie Williams voices concern over eyesight decline

Robbie Williams fears his weight-loss injections are damaging his vision, saying his eyesight has grown increasingly blurry in recent months. The 51-year-old, who has been using Mounjaro, believes the jab may be behind the sudden decline and wants others to be aware of possible side effects.

He told The Sun he first noticed something was wrong while watching an American football game, when the players appeared “just shapes on the field”. An optician later prescribed new glasses, but Williams said he hadn’t initially linked the problem to the injections.

Keep ReadingShow less